Views

Read op-eds and interviews from our staff, allies and partners.

Angelina Namiba: changing the narrative of black women with HIV

Last updated:

Originally from Kenya, and a National AIDS Trust trustee, Angelina is experienced in providing one-to-one support, treatment advocacy, managing service delivery, and advocating for the involvement of women living with HIV in strategy and policy.

Trans rights threats jeopardise HIV equality progress

Last updated:

Kat Smithson writes about our deep concerned about the impact of negative references to trans people in the UK from those in Government on the lives of trans people in the UK. We stand with our trans friends and colleagues in the HIV community and beyond.

Black History Month: Reverend Jide Macaulay

Last updated:

For Black History Month we spoke with Reverend Jide Macaulay (he/him), Founder and CEO of House of Rainbow CIC, a gay British Nigerian, inspirational speaker, author, poet, pastor, preacher and HIV Positive activist.

BHIVA Spring Conference 2023: PrEP, testing, quality of life

Last updated:

Adam Freedman, our Policy, Research and Influencing Manager, write how the BHIVA Spring Conference was a chance to learn about the latest developments in HIV medicine and healthcare. A running theme was the shared desire to improve the experiences of people living with, or at risk of acquiring, HIV within the healthcare system.

Lesbian Visibility Day: Lisa Power on activism and solidarity

Last updated:

Lisa Power is a British LGBT+ rights activist. She was one of the founding members of the lesbian and gay rights group Stonewall in 1989, which has played a pivotal role in achieving legal recognition and protection for LGBT+ people in the UK.

New CPS HIV transmission guidance is clear: U=U

Last updated:

Kat Smithson shares that since 2001 it has been possible to be prosecuted for the reckless or intentional transmission of HIV in England and Wales. We’re pleased that this week, long overdue changes to the CPS’s guidance have been published.

Women being failed in the fight against HIV

Last updated:

Winnie Sseruma writes that the game-changing HIV prevention drug PrEP is a vital tool to end new HIV transmissions. But a 2022 report showed that many who might benefit from PrEP were not currently able to access it, including women and those from racially minoritised communities.